Tackling Cardiovascular Risk: New Evidence from Personalized Medicine / Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida, Michele Ciccarelli
Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies. Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Current pharmacogenomics and personalized medicine - 15(2017), 1, Seite 60- |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Finelli, Rosa [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Umfang: |
1 Online-Ressource (7 p) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
KFL009084193 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL009084193 | ||
003 | DE-627 | ||
005 | 20231129104159.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220323s2017 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)KFL009084193 | ||
035 | |a (KFL)prod_DARH_010AF.sgm.5275A362E7E8A808830A4811ED65FB0A39CEDAC8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Finelli, Rosa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tackling Cardiovascular Risk: New Evidence from Personalized Medicine |c Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida, Michele Ciccarelli |
264 | 1 | |c 2017 | |
300 | |a 1 Online-Ressource (7 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies. Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap | ||
700 | 1 | |a Pascale, Antonietta V. |e verfasserin |4 aut | |
700 | 1 | |a Marotta, Paola |e verfasserin |4 aut | |
700 | 1 | |a Guida, Anna |e verfasserin |4 aut | |
700 | 1 | |a Ciccarelli, Michele |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current pharmacogenomics and personalized medicine |d Sharjah : Bentham, 2008 |g 15(2017), 1, Seite 60- |h Online-Ressource |w (DE-627)KFL000006556 |w (DE-600)2424232-9 |w (DE-576)30683636X |x 1875-6913 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2017 |g number:1 |g pages:60- |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1875-6921&volume=15&issue=1&spage=60 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-BEJ | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
935 | |i IMPORT_0628_prod_DARH_01 | ||
951 | |a AR | ||
952 | |d 15 |j 2017 |e 1 |h 60- |